SCHEMBL2811194

SCHEMBL2811194

Nc1nc(C(=O)O)c(C(=O)O)[nH]1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 8/20 0.48
CYP1A2 P05177 2/20 0.48
MAPK1 P28482 1/20 0.48
CASP1 P29466 1/20 0.48
CYP2C19 P33261 1/20 0.48
ALDH1A1 P00352 2/20 0.42
HIF1A Q16665 1/20 0.42
TDP1 Q9NUW8 2/20 0.36
AKR1B1 P15121 1/20 0.35
TSHR P16473 1/20 0.34
CDK1 P06493 1/20 0.32
CDK4 P11802 1/20 0.32
CDK2 P24941 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PNP P00491 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9847453 0.77 CDK1 (0.36) PIN1CYP1A2MAPK1CASP1CYP2C19
SCHEMBL13613552 0.76 TDP1 (0.44) PIN1CYP1A2MAPK1CASP1CYP2C19
SCHEMBL28169947 0.74 PIN1 (0.50) PIN1CYP1A2MAPK1CASP1CYP2C19
SCHEMBL11475671 0.74 PIN1 (0.50) PIN1CYP1A2MAPK1CASP1CYP2C19
SCHEMBL10403221 0.73 PIN1 (0.48) PIN1CYP1A2MAPK1CASP1CYP2C19
SCHEMBL9280474 0.73 PIN1 (0.48) PIN1CYP1A2MAPK1CASP1CYP2C19
SCHEMBL213561 0.73 PIN1 (0.48) PIN1CYP1A2MAPK1CASP1CYP2C19
SCHEMBL2522013 0.73 PIN1 (0.48) PIN1CYP1A2MAPK1CASP1CYP2C19
SCHEMBL14468605 0.72 CYP1A2 (0.40) PIN1CYP1A2MAPK1CASP1CYP2C19
SCHEMBL11491730 0.71 PIN1 (0.47) PIN1CYP1A2MAPK1CASP1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119307163-A Non-stick pan coating, preparation method thereof and pan 河北立德尔炊具股份有限公司 2025-01-14 CN claimed
US-8968711-B2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process L'OREAL (FR) 2015-03-03 US claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US claimed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US claimed
US-20250276300-A1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2025-09-04 US disclosed
EP-4291588-B1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2025-08-20 EP disclosed
CN-119307163-A Non-stick pan coating, preparation method thereof and pan 河北立德尔炊具股份有限公司 2025-01-14 CN disclosed
EP-4291588-A1 REDUCTION OF MONOMERIC ISOCYANATES BY POROUS MATERIAL BASF SE (DE) 2023-12-20 EP disclosed
CN-116829611-A Reduction of monomeric isocyanates by porous materials 巴斯夫欧洲公司 2023-09-29 CN disclosed
EP-4204100-A1 HAIR LIGHTENING COMPOSITIONS PROVIDING DAMAGE PROTECTION AND SENSORIAL BENEFITS AND METHODS OF USE L'OREAL (FR) 2023-07-05 EP disclosed
CN-116322616-A Hair lightening compositions providing damage protection and sensory benefits and methods of use 欧莱雅 2023-06-23 CN disclosed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US disclosed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US disclosed
US-20090028807-A1 COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION L'OREAL (FR) 2009-01-29 US disclosed
US-6737517-B2 AZO GROUP CONTAINING TRANSITION METAL COMPLEX DYE EXHIBITS A GOOD ACHROMATICITY AS WELL AS A GOOD LIGHT-RESISTANCE MITSUBISHI CHEMICAL CORPORATION (JP) 2004-05-18 US disclosed
US-20030149251-A1 Metal chelated azo dyestuff for inkjet recording and recording liquid for inkjet and inkjet recording method using same MITSUBISHI CHEMICAL CORPORATION (JP) 2003-08-07 US disclosed
EP-1260556-A1 METAL CHELATE AZO DYE FOR INK-JET RECORDING, INK-JET RECORDING FLUID CONTAINING THE SAME, AND METHOD OF INK-JET RECORDING MITSUBISHI CHEMICAL CORPORATION (JP) 2002-11-27 EP disclosed
US-4662905-A REACTION PRODUCT OF COPPER SALT AND AN IMIDAZOLE, PYRAZOLE, TRIAZOLE, OR TETRAZOLE Itaru Todoriki, Director of Agency of Industrial Science and Technology (JP) 1987-05-05 US disclosed
US-4217450-A ANTIBIOTICS, BACTERICIDES AJINOMOTO COMPANY, INCORPORATED (JP) 1980-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 PIN1 44/4885CYP1A2 3261/4885MAPK1 2309/4885
US-20090028807-A1 COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION CUTA, SYMPK, TPRKB PIN1 2619/4885CYP1A2 4735/4885MAPK1 4102/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA PIN1 1587/4885CYP1A2 1104/4885MAPK1 2694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.